• FirefoxInstall the new Firefox »
  •  Dow Down0.66% Nasdaq Down0.80%

    More On SBM.V

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Sirona Biochem Corp. (SBM.V)

    -TSXV
    0.17 Down 0.01(2.94%) 11:43AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Sirona Biochem Corp.
    605-889 West Pender Street
    Vancouver, BC V6C 3B2
    Canada - Map
    Phone: 604-641-4466
    Fax: 604-608-5471
    Website: http://www.sironabiochem.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:N/A

    Business Summary 

    Sirona Biochem Corp. operates as a cosmetic ingredient and drug discovery company in Canada. The company develops programs in three areas, including diabetes and cancer therapeutics; anti-aging and depigmenting agent in cosmeceuticals; biological ingredients, such as inducers and adjuvants for biological development. It develops a sodium glucose co-transporter inhibitor for the treatment of Type 2 diabetes; and a cancer vaccine antigen. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Sirona Biochem Corp.

    Key Executives 
     PayExercised
    Dr. Howard J. Verrico M.D., 54
    Founder, Chairman, Interim Chief Exec. Officer, Sec. and Member of Audit Committee
    145.00K0.00
    Mr. Christopher D. Hopton C.G.A., 49
    Chief Financial Officer and Director
    152.00K0.00
    Dr. G Deliencourt-Godefroy Ph.D.,
    Chief Scientific Officer and Director
    12.00K0.00
    Ms. Michelle Seltenrich ,
    VP of Operations
    N/AN/A
    Ms. Julie Jang ,
    Director of Communications
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in CAD.